Antiretroviral medication and HIV prevention: New steps forward and new questions

Annals of Internal Medicine

Volumn 156, Issue 4, 2012, Pages 312-314

  Mayer, Kenneth H ^a   Krakower, Douglas ^b  

^a FENWAY INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; PLACEBO; TENOFOVIR DISOPROXIL;

ANTIVIRAL THERAPY; ARTICLE; CHEMOPROPHYLAXIS; HEALTH CARE PERSONNEL; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MORBIDITY; MORTALITY; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRUS TRANSMISSION;

EID: 84857180352     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-4-201202210-00383     Document Type: Article

References (14)

1. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-74. [PMID: 20643915]
2. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-99. [PMID: 21091279]
3. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505. [PMID:21767103]
4. Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G, Cremin I, et al. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med. 2011;8:e1001123. [PMID: 22110407]
5. Abbas U, Glaubius R, Mubayi A, Hood G, Mellors J. Predicting the impact of ART and PrEP with overlapping regimens on HIV transmission and drug resistance in South Africa [Abstract]. Presented at the 18th Conference on Retroviruses and Opportunistic Infections, Boston, 27 February-2 March 2011. Abstract 98LB. Accessed at:www.retroconference.org/2011/Abstracts/42475.htm on 12 December 2011.
6. Family Health International. FEM-PrEP June 2011 update. Accessed at www.fhi360.org/NR/rdonlyres/erj6hevouwvddigjldvcca6tvtybfolh4nedyfeo4yz2i7la53jknim6ex42bme2rvyq6zfzovyrkb/FEMPrEPFactSheetJune2011.pdf on 8 January 2012.
7. Baeten J, Celum C. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: the Partners PrEP study [Abstract]. Presented at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, Rome, Italy, 17-20 July 2011. Abstract MOAX0106. Accessed at http://pag.ias2011.org/flash.aspx?pid_886 on 12 December 2011.
8. Thigpen MC, Kebaabetswe PM, Smith DK, Segolodi TM, Soud FA, Chillag K, et al. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study [Abstract]. Presented at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, Rome, Italy, 17-20 July 2011. Abstract WELBC01. Accessed at http://pag.ias2011.org/abstracts.aspx?aid_4631 on 12 December 2011.
9. MTN statement on decision to discontinue use of tenofovir gel in VOICE, A major HIV prevention study in women [Press release]. Pittsburgh, PA: Microbicide Trials Network; 25 November 2011. Accessed at www.mtnstopshiv.org/node/3909 on 8 January 2012.
10. Hendrix C, Minnis A, Guddera V, Riddler S, Salata R, Nakabiito C, et al. MTN-001: a phase 2 cross-over study of daily oral and vaginal TFV in healthy, sexually active women results in significantly different product acceptability and vaginal tissue drug concentrations [Abstract]. Presented at the 18th Conference on Retroviruses and Opportunistic Infections, Boston, 27 February-2 March 2011. Abstract 35LB. Accessed at www.retroconference.org/2011/Abstracts/42418.htm on 12 December 2011.
11. Kashuba AD, Patterson KB, Dumond JB, Cohen MS. Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet. 2011. [PMID: 22153566]
12. FACTS Consortium. FACTS 001 study. 2011. Accessed at www.facts-consortium.co.za/?page_id_83 on 12 December 2011.
13. Office of the Press Secretary, The White House. Fact sheet: the beginning of the end of AIDS. 1 December 2011. Accessed at www.whitehouse.gov/the-press-office/2011/12/01/fact-sheet-beginning-end-aids on 12 December 2011.
14. UNAIDS. Report on the Global AIDS Epidemic 2010. Geneva: UNAIDS; 2010. Accessed at www.unaids.org/GlobalReport/default.htm on 12 December 2011.